New study tracks Octreotide's Real-World impact on acromegaly over two years

NCT ID NCT07583563

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 4 times

Summary

This study follows 200 people with acromegaly who are using octreotide subcutaneous depot, a medication that helps control hormone levels. Researchers will monitor safety and effectiveness for up to two years in everyday clinical practice, not a controlled lab setting. The goal is to see how well the drug works in real life and what side effects may occur.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
octreotide subcutaneous depot
What this could lead to
If successful, this study could confirm that octreotide SC depot is a safe and effective long-term treatment option for managing acromegaly in everyday practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. It does not test a new drug but gathers real-world data on an existing treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie

    RECRUITING

    Magdeburg, 39110, Germany

  • Medicover Neuroendokrinologie MVZ

    NOT_YET_RECRUITING

    München, 81667, Germany

  • St James's University Hospital - Leeds Teaching Hospitals NHS Trust

    NOT_YET_RECRUITING

    Leeds, LS9 7TF, United Kingdom

  • Universitaetsklinikum Aachen

    NOT_YET_RECRUITING

    Aachen, 52074, Germany

  • Universitaetsklinikum Leipzig

    RECRUITING

    Leipzig, 04103, Germany

  • Universitätsklinikum Würzburg

    RECRUITING

    Würzburg, 97080, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.